Open Orphan Plc (LON:ORPH – Get Free Report) was up 5.3% during trading on Tuesday . The company traded as high as GBX 10.38 ($0.13) and last traded at GBX 10 ($0.13). Approximately 652,639 shares traded hands during mid-day trading, a decline of 58% from the average daily volume of 1,559,247 shares. The stock had previously closed at GBX 9.50 ($0.12).
Open Orphan Trading Up 5.3 %
The company has a debt-to-equity ratio of 10.88, a quick ratio of 1.16 and a current ratio of 1.19. The company has a market cap of £67.09 million and a price-to-earnings ratio of -25.30. The company’s fifty day moving average is GBX 10 and its two-hundred day moving average is GBX 10.
Open Orphan Company Profile
Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Further Reading
- Five stocks we like better than Open Orphan
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- With Risk Tolerance, One Size Does Not Fit All
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- The 3 Best Blue-Chip Stocks to Buy Now
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Open Orphan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Open Orphan and related companies with MarketBeat.com's FREE daily email newsletter.